|
The FINANCIAL -- The Commission proposal for a revised „Transparency Directive‟ published will improve Member States‟ procedural framework for pricing and reimbursement of medicines to accelerate patient access to innovation. In the current difficult economic context in Europe, however, more needs to be done to ensure fair access for all EU patients to pharmaceutical treatment. |
|
| Read more... | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
